Given this substantial number of downregulated tumor suppressors and elevation of cdk1 and cdk4, we conclude that fusion-positive HBLs/HCN-NOSs have more severe liver cancers relative to fusion-negative HBLs. This evidence concerns the gene CDK1 and neoplasm.